相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phosphodiesterase 5 (PDE5): Structure-function regulation and therapeutic applications of inhibitors
Wesam S. Ahmed et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
In vitro susceptibility of Trypanosoma cruzi discrete typing units (DTUs) to benznidazole: A systematic review and meta-analysis
Andrea Vela et al.
PLOS NEGLECTED TROPICAL DISEASES (2021)
Precision Health for Chagas Disease: Integrating Parasite and Host Factors to Predict Outcome of Infection and Response to Therapy
Santiago J. Martinez et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study
Jianfeng Xie et al.
INTENSIVE CARE MEDICINE (2020)
Advances in preclinical approaches to Chagas disease drug discovery
Fernando Villalta et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Imidazole Derivatives as Promising Agents for the Treatment of Chagas Disease
Juliann Siciliano de Araujo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Revisiting the Trypanosoma cruzi metacyclogenesis: morphological and ultrastructural analyses during cell differentiation
Camila Silva Goncalves et al.
PARASITES & VECTORS (2018)
ADMETopt: A Web Server for ADMET Optimization in Drug Design via Scaffold Hopping
Hongbin Yang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Heng Li et al.
FRONTIERS IN PHARMACOLOGY (2018)
Experimental and Clinical Treatment of Chagas Disease: A Review
Policarpo Ademar Sales Junior et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Clinical Candidate VT-1161's Antiparasitic Effect In Vitro, Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex with the Target Enzyme CYP51 from Trypanosoma cruzi
William J. Hoekstra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Current drug therapy and pharmaceutical challenges for Chagas disease
Jose Bermudez et al.
ACTA TROPICA (2016)
Early Regulation of Profibrotic Genes in Primary Human Cardiac Myocytes by Trypanosoma cruzi
Aniekanabassi N. Udoko et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis
Galina I. Lepesheva et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity
Andrea Nuehs et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!
Daniel N. A. Tagoe et al.
FRONTIERS IN PHARMACOLOGY (2015)
Lead Identification to Clinical Candidate Selection: Drugs for Chagas Disease
R. Jeffrey Neitz et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Susceptibilidad in vitro a hexadecilfosfocolina (miltefosina), nifurtimox y benznidazole de cepas de Trypanosoma cruzi aisladas en Santander, Colombia
Patricia Escobar et al.
Biomedica (2014)
Clinical and Molecular Genetics of the Phosphodiesterases (PDEs)
Monalisa F. Azevedo et al.
ENDOCRINE REVIEWS (2014)
Chagas disease: the challenge of polyparasitism?
Catherine J. Perez et al.
TRENDS IN PARASITOLOGY (2014)
Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay
Manu De Rycker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Extracellular amastigotes of Trypanosoma cruzi are potent inducers of phagocytosis in mammalian cells
Maria Cecilia Fernandes et al.
CELLULAR MICROBIOLOGY (2013)
VNI Cures Acute and Chronic Experimental Chagas Disease
Fernando Villalta et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation
Belinda S. Hall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments
Therese Keravis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Development of Luciferase Expressing Leishmania donovani Axenic Amastigotes as Primary Model for In Vitro Screening of Antileishmanial Compounds
Ravinder et al.
CURRENT MICROBIOLOGY (2012)
The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications
Bianca Zingales et al.
INFECTION GENETICS AND EVOLUTION (2012)
Biological and Structural Characterization of Trypanosoma cruzi Phosphodiesterase C and Implications for Design of Parasite Selective Inhibitors
Huanchen Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Thrombospondin-1 Interacts with Trypanosoma cruzi Surface Calreticulin to Enhance Cellular Infection
Candice A. Johnson et al.
PLOS ONE (2012)
Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation
Pascale Pescher et al.
CELLULAR MICROBIOLOGY (2011)
Profiling of a Prescription Drug Library for Potential Renal Drug-Drug Interactions Mediated by the Organic Cation Transporter 2
Yasuto Kido et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
A Novel Approach for Predicting P-Glycoprotein (ABCB1) Inhibition Using Molecular Interaction Fields
Fabio Broccatelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Defining the role of a FYVE domain in the localization and activity of a cAMP phosphodiesterase implicated in osmoregulation in Trypanosoma cruzi
Alejandra C. Schoijet et al.
MOLECULAR MICROBIOLOGY (2011)
ChemMine tools: an online service for analyzing and clustering small molecules
Tyler W. H. Backman et al.
NUCLEIC ACIDS RESEARCH (2011)
Chemical Validation of Phosphodiesterase C as a Chemotherapeutic Target in Trypanosoma cruzi, the Etiological Agent of Chagas' Disease
Sharon King-Keller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Trypanosoma cruzi: Biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs
Noelia L. Grosso et al.
EXPERIMENTAL PARASITOLOGY (2010)
Structural Insights into Inhibition of Sterol 14α-Demethylase in the Human Pathogen Trypanosoma cruzi
Galina I. Lepesheva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Neurological manifestations of Chagas' disease
Ezequiel Cordova et al.
NEUROLOGICAL RESEARCH (2010)
Whole-genome comparative RNA expression profiling of axenic and intracellular amastigote forms of Leishmania infantum
Annie Rochette et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2009)
A new genotype of Trypanosoma cruzi associated with bats evidenced by phylogenetic analyses using SSU rDNA, cytochrome b and Histone H2B genes and genotyping based on ITS1 rDNA
A. Marcili et al.
PARASITOLOGY (2009)
Perspectives on Trypanosoma cruzi-Induced Heart Disease (Chagas Disease)
Herbert B. Tanowitz et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2009)
Rapid fluorescent assay for screening drugs on Leishmania amastigotes
Orly Shimony et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2008)
Cyclic nucleotide signaling mechanisms in trypanosomes: Possible targets for therapeutic agents
Sunil Laxman et al.
MOLECULAR INTERVENTIONS (2007)
The Trypanosoma brucei cAMP phosphodiesterases TbrPDEB1 and TbrPDEB2:: flagellar enzymes that are essential for parasite virulence
Michael Oberholzer et al.
FASEB JOURNAL (2007)
Characterization of a novel cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypanosoma cruzi
Rocio Diaz-Benjumea et al.
BIOCHEMICAL JOURNAL (2006)
TcPDE4, a novel membrane-associated cAMP-specific phosphodiesterase from Trypanosoma cruzi
GD Alonso et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2006)
Invasion of MDCK epithelial cells with altered expression of Rho GTPases by Trypanosoma cruzi amastigotes and metacyclic trypomastigotes of strains from the two major phylogenetic lineages
AB Fernandes et al.
MICROBES AND INFECTION (2004)
Generation of Leishmania donovani axenic amastigotes:: their growth and biological characteristics
A Debrabant et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2004)
cAMP signalling in the kinetoplastid protozoa
T Seebeck et al.
CURRENT MOLECULAR MEDICINE (2004)
Drug-drug interactions for UDP-glucuronosyltransferase substrates:: A pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios
JA Williams et al.
DRUG METABOLISM AND DISPOSITION (2004)
Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts
PMD Guedes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The discovery of tadalafil:: A novel and highly selective PDE5 inhibitor.: 1:: 5,6,11,11a-tetrahydro-1H-imidazo[1′,5′:1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues
A Daugan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors
YG Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania species
MCA Teixeira et al.
PARASITOLOGY RESEARCH (2002)
Zaprinast, an inhibitor of cGMP-selective phosphodiesterases, enhances the secretion of TNF-α and IL-1β and the expression of iNOS and MHC class II molecules in rat microglial cells
SH Choi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
A critical review on Chagas disease chemotherapy
JR Coura et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
分享论文
